M. Guill Wientjes

559 total citations
11 papers, 451 citations indexed

About

M. Guill Wientjes is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, M. Guill Wientjes has authored 11 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in M. Guill Wientjes's work include Nanoparticle-Based Drug Delivery (2 papers), Cell death mechanisms and regulation (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). M. Guill Wientjes is often cited by papers focused on Nanoparticle-Based Drug Delivery (2 papers), Cell death mechanisms and regulation (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). M. Guill Wientjes collaborates with scholars based in United States. M. Guill Wientjes's co-authors include Jessie L.‐S. Au, Ze Lu, Max Tsai, Teng‐Kuang Yeh, Seong H. Jang, Jenny Zheng, Chiung‐Tong Chen, Robert A. Badalament, Yuebo Gan and James J. Ashton and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Controlled Release.

In The Last Decade

M. Guill Wientjes

11 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Guill Wientjes United States 9 155 138 100 94 74 11 451
Derya İlem‐Özdemir Türkiye 13 177 1.1× 103 0.7× 140 1.4× 80 0.9× 94 1.3× 55 580
Kaori Hara Japan 8 123 0.8× 104 0.8× 67 0.7× 121 1.3× 128 1.7× 18 476
Yeong Woo Jo South Korea 10 83 0.5× 135 1.0× 140 1.4× 67 0.7× 15 0.2× 17 489
Qingsi Wu China 13 110 0.7× 192 1.4× 85 0.8× 36 0.4× 25 0.3× 18 602
Heping Qiu China 11 118 0.8× 93 0.7× 176 1.8× 82 0.9× 23 0.3× 19 392
Zhouxue Wu China 13 272 1.8× 150 1.1× 223 2.2× 48 0.5× 51 0.7× 24 572
Pierre‐Alain Burnouf Taiwan 12 221 1.4× 456 3.3× 173 1.7× 32 0.3× 42 0.6× 15 738
Somayeh Shahreza United Kingdom 8 156 1.0× 157 1.1× 138 1.4× 60 0.6× 53 0.7× 10 452
Boyang Sun China 13 112 0.7× 158 1.1× 226 2.3× 22 0.2× 107 1.4× 32 528
E. Yu. Moskaleva Russia 7 178 1.1× 140 1.0× 82 0.8× 24 0.3× 19 0.3× 37 390

Countries citing papers authored by M. Guill Wientjes

Since Specialization
Citations

This map shows the geographic impact of M. Guill Wientjes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Guill Wientjes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Guill Wientjes more than expected).

Fields of papers citing papers by M. Guill Wientjes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Guill Wientjes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Guill Wientjes. The network helps show where M. Guill Wientjes may publish in the future.

Co-authorship network of co-authors of M. Guill Wientjes

This figure shows the co-authorship network connecting the top 25 collaborators of M. Guill Wientjes. A scholar is included among the top collaborators of M. Guill Wientjes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Guill Wientjes. M. Guill Wientjes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Yan, Xin, et al.. (2004). Low-dose suramin enhances antitumor activity of mitomycin C in bladder tumors. Cancer Research. 64. 461–461. 3 indexed citations
2.
Lu, Ze, Teng‐Kuang Yeh, Max Tsai, Jessie L.‐S. Au, & M. Guill Wientjes. (2004). Paclitaxel-Loaded Gelatin Nanoparticles for Intravesical Bladder Cancer Therapy. Clinical Cancer Research. 10(22). 7677–7684. 189 indexed citations
3.
Au, Jessie L.‐S., Seong H. Jang, & M. Guill Wientjes. (2002). Clinical aspects of drug delivery to tumors. Journal of Controlled Release. 78(1-3). 81–95. 66 indexed citations
4.
Zheng, Jenny, Chiung‐Tong Chen, Jessie L.‐S. Au, & M. Guill Wientjes. (2001). Time-and concentration-dependent penetration of doxorubicin in prostate tumors. PubMed. 3(2). 69–77. 58 indexed citations
5.
6.
Au, Jessie L.‐S., et al.. (1999). Kinetics of hallmark biochemical changes in paclitaxel-induced apoptosis. PubMed. 1(3). 7–14. 27 indexed citations
7.
Gan, Yuebo, M. Guill Wientjes, Jie Lu, & Jessie L.‐S. Au. (1998). Cytostatic and apoptotic effects of paclitaxel in human breast tumors. Cancer Chemotherapy and Pharmacology. 42(3). 177–182. 19 indexed citations
8.
Wientjes, M. Guill, Thomas G. Pretlow, Robert A. Badalament, John K. Burgers, & Jessie L.‐S. Au. (1995). Histocultures of Human Prostate Tissues for Pharmacologic Evaluation. The Journal of Urology. 153(4). 1299–1302. 10 indexed citations
9.
Drago, Joseph R., Robert A. Badalament, M. Guill Wientjes, et al.. (1989). Relative value of prostate-specific antigen and prosttic acid phosphatase in diagnosis and management of adenocarcinoma of prostate Ohio State University Experience. Urology. 34(4). 187–192. 46 indexed citations
10.
Au, J. Lai‐Sim, Muh‐Hwan Su, & M. Guill Wientjes. (1987). Isocratic ion-pair reversed-phase high-performance liquid chromatographic analysis of ATP and ADP. Journal of Chromatography B Biomedical Sciences and Applications. 423. 308–312. 12 indexed citations
11.
Wientjes, M. Guill & J. Lai‐Sim Au. (1987). Inhibition of Intestinal Pyrimidine Nucleoside Phosphorylases. Pharmaceutical Research. 4(5). 425–428. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026